STRUCTURE-ACTIVITY-RELATIONSHIPS OF CADEGUOMYCIN ANALOGS

被引:1
作者
KIM, SH
OKAZAKI, K
OKABE, T
NISHIMURA, T
KONDO, T
TANAKA, N
SUZUKI, H
机构
[1] UNIV TOKYO,INST APPL MICROBIOL,1-1-1 YAYOI,BUNKYO KU,TOKYO 113,JAPAN
[2] NAGOYA UNIV,CTR CHEM INSTRUMENT,CHIKUSA KU,NAGOYA 46401,JAPAN
关键词
D O I
10.7164/antibiotics.44.659
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The relationship between the activity and the chemical structure of cadeguomycin (CDM, 7-carboxy-7-deazaguanosine) was studied with six analogs of CDM. Both activities of CDM, enhancing the incorporation of [H-3]thymidine in K562 cells and potentiating the cytotoxicity of cytosine arabinoside for K562 cells, were significantly augmented by the replacement of the 7-carboxyl group with cyano (CDM-CN) or formyl (CDM-CHO), but they were not changed by the replacement with methyl. The activities were almost completely diminished by the replacement of ribose with arabinose, but the simultaneous replacement of carboxyl and ribose with formyl and arabinose showed higher activities than those of CDM. The replacement of 7-carboxy-7-deazaguanine with 7-carboxy-7-deazainosine markedly weakened the activity. CDM-CN and CDM-CHO at 0.2-mu-g/ml significantly potentiated the activity of cytosine arabinoside against MOLT-3 cells but CDM at 1-mu-g/ml did not. These results indicate that the ribose and guanine moieties in the CDM molecule are very important for its activity. Also replacing the carboxyl group at the C-7 position with cyano or formyl group is a useful way to strengthen the CDM activity. These compounds would effectively potentiate cytosine arabinoside against various kinds of tumor cells which CDM could not do.
引用
收藏
页码:659 / 664
页数:6
相关论文
共 19 条
[1]  
ANZAI K, 1957, J ANTIBIOT, V10, P201
[2]   NUCLEOSIDE ANTIBIOTICS - STRUCTURE, BIOLOGICAL-ACTIVITY, AND BIOSYNTHESIS [J].
ISONO, K .
JOURNAL OF ANTIBIOTICS, 1988, 41 (12) :1711-1739
[3]   STRUCTURE OF MODIFIED NUCLEOSIDE-Q ISOLATED FROM ESCHERICHIA-COLI TRANSFER RIBONUCLEIC-ACID - 7-(4,5-CIS-DIHYDROXY-1-CYCLOPENTEN-3-YLAMINOMETHYL)-7-DEAZAGUANOSINE [J].
KASAI, H ;
OHASHI, Z ;
HARADA, F ;
NISHIMURA, S ;
OPPENHEIMER, NJ ;
CRAIN, PF ;
LIEHR, JG ;
MINDEN, DLV ;
MCCLOSKEY, JA .
BIOCHEMISTRY, 1975, 14 (19) :4198-4208
[4]   EFFECTS OF CADEGUOMYCIN ON CYTOTOXICITY OF CYTOSINE-ARABINOSIDE AND OTHER PYRIMIDINE NUCLEOSIDE ANALOGS - A COMPARATIVE-STUDY [J].
KIM, SH ;
OKABE, T ;
TANAKA, N ;
SUZUKI, H .
JOURNAL OF ANTIBIOTICS, 1987, 40 (12) :1776-1777
[5]   SYNTHESES OF HYPERMODIFIED NUCLEOSIDE-Q, AND ITS BIOSYNTHETIC PRECURSORS PREQ0 AND PREQ1 [J].
KONDO, T ;
OKAMOTO, K ;
OHGI, T ;
GOTO, T .
TETRAHEDRON, 1986, 42 (01) :207-213
[6]   A TOTAL SYNTHESIS OF CADEGUOMYCIN, A NUCLEOSIDE ANTIBIOTIC PRODUCED BY STREPTOMYCES HYGROSCOPICUS [J].
KONDO, T ;
OKAMOTO, K ;
YAMAMOTO, M ;
GOTO, T ;
TANAKA, N .
TETRAHEDRON, 1986, 42 (01) :199-205
[7]  
LOOMIS CR, 1988, J BIOL CHEM, V263, P1682
[8]  
LOZZIO CB, 1975, BLOOD, V45, P32
[9]  
MINOWADA J, 1972, J NATL CANCER I, V49, P891
[10]   KANAGAWAMICIN - A NEW AMINONUCLEOSIDE ANALOG ANTIBIOTIC FROM ACTINOPLANES-KANAGAWAENSIS [J].
NARUTO, S ;
UNO, H ;
TANAKA, A ;
KOTANI, H ;
TAKASE, Y .
HETEROCYCLES, 1983, 20 (01) :27-32